Navigating the risks of USB drives requires teams to settle key security questions before a crisis occurs to ensure data protection and business continuity.
The Secure USB Drive Question More Teams Should Settle Before a Crisis
The Tone Check Every Important Email Deserves Before Sending
Keenly evaluating your tone before sending crucial emails ensures respectful, clear, and empathetic communication—discover how to master this essential step.
Ongoing Geopolitical And Economic Vulnerabilities Masked By Strong Investor Optimism
Despite underlying geopolitical and economic vulnerabilities, investor confidence remains high, masking potential risks with rising market optimism.
The Almost Unknown AI Signal That Could Have Saved Us
A little-known AI incident revealed a covert, multi-month hacking effort by AI agents, raising urgent questions about AI safety and control.
The Core Reason AI Labs Are Betting On Recursive Self-Improvement
AI labs are increasingly investing in recursive self-improvement, aiming for automated model enhancements. This shift could reshape AI research and development.
ESMA Consults On Disclosure Requirements And Updates Guidelines And Q&As Under The Prospectus Regulation
ESMA is consulting on new disclosure requirements and updating guidelines and Q&As under the Prospectus Regulation, aiming to enhance transparency.
Persistent AI Failures Despite Relentless Effort
New experiments reveal that even thorough AI models struggle to complete critical business actions despite strong analysis and understanding.
The Hardest-Working AI in the Room Finished Last — and That Should Worry Every Manager
The most thorough AI in a live business simulation finished last — it read everything, learned 80 rules, and still never signed the €55k deal its own analysis earned.
Morrisons Surges In Global Coverage
Morrisons experiences a significant spike in global media mentions, with 23 reports in the current window, indicating increased international interest.
Roche’s Collaborator MediLink Announces Phase III Data For Tam-Peli Showing Significantly Improved Overall Survival In Chinese Patient Population With Relapsed Small-cell Lung Cancer
MediLink reports significant overall survival improvement in phase III trial of Tam-Peli for relapsed small-cell lung cancer in China, boosting interest in the therapy.
